Menü
Das neue sharewise ist da Übersichtlicher, schneller, mit heller und dunkler Ansicht — und allem, was du kennst. Jetzt ausprobieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?Photo, wide shot, wide-angle lens,  Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

The State Street SPDR S&P Pharmaceuticals ETF (XPH) made its debut on 06/19/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the

Geospace Technologies Q3 Earnings Call HighlightsPhoto, wide shot, wide-angle lens,  Coal company, neutral atmosphere, photo by Galina Stepanova: https://img.theapi.app/temp/0e838f13-fa33-4583-92e9-bf3375dacf70.png
Geospace Technologies Q3 Earnings Call Highlights

Key Points

Should iShares MSCI USA Value Factor ETF (VLUE) Be on Your Investing Radar?
Should iShares MSCI USA Value Factor ETF (VLUE) Be on Your Investing Radar?

If you're interested in broad exposure to the Large Cap Value segment of the US equity market, look no further than the iShares MSCI USA Value Factor ETF (VLUE), a passively managed exchange traded

AEM Stock Pops 25% in a Month: What Should Investors Do Now?: https://pixabay.com/de/photos/gold-ingots-golden-schatz-513062/
AEM Stock Pops 25% in a Month: What Should Investors Do Now?

Agnico Eagle Mines Limited’s AEM shares have rallied 24.6% in the past month, thanks to a rebound in gold prices and the company’s forecast-topping earnings performance in the second quarter driven

URBN vs. ZGN: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Online marketplace, sunset photo at golden hour, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/27d484d8-d1b1-4519-9797-b5dcaa68d4e2.png
URBN vs. ZGN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Retail - Apparel and Shoes sector might want to consider either Urban Outfitters (URBN) or Ermenegildo Zegna N.V. (ZGN). But which of these two companies is the

ALRM or ASAZY: Which Is the Better Value Stock Right Now?
ALRM or ASAZY: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Security and Safety Services sector might want to consider either Alarm.com Holdings (ALRM) or Assa Abloy AB (ASAZY). But which of these two companies is the best

Medical Properties Trust Q2 Earnings Call Highlights
Medical Properties Trust Q2 Earnings Call Highlights

Key Points

Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks NowPhoto, wide shot, wide-angle lens,  Restaurant, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/6d1f34ee-79e7-4628-b30f-0a4597808d61.png
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

SNEX Drops 14% in One Week: Is the Pullback a Buying Opportunity?
SNEX Drops 14% in One Week: Is the Pullback a Buying Opportunity?

StoneX Group Inc. SNEX shares fell 14% in the past week, a sharp reversal for a stock that is still up 16.2% over six months. The pullback comes after fiscal third-quarter results showed broad

SCCO Stock Rise 41% YTD: What's the Right Strategy for Investors Now?Photo, wide shot, wide-angle lens,  Gold mine, Midday, harsh overhead sunlight, directional sunlightt, photo by Thomas Heaton: https://img.midjourneyapi.xyz/temp/94faf2bd-99c1-4ea6-b55d-fdcab23c3865.png
SCCO Stock Rise 41% YTD: What's the Right Strategy for Investors Now?

Southern Copper Corporation SCCO shares have gained 40.9% year to date compared with the Zacks Mining - Non Ferrous industry’s rise of 25%. During this time, the Basic Materials sector has risen

Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?
Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?

If you're interested in broad exposure to the Mid Cap Blend segment of the US equity market, look no further than the Invesco S&P MidCap Quality ETF (XMHQ), a passively managed exchange traded fund

Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks NowPhoto, wide shot, wide-angle lens,  Department store, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/57f223bf-67a0-476b-94dd-76010fccb266.png
Why Investors Need to Take Advantage of These 2 Retail and Wholesale Stocks Now

Earnings are arguably the most important single number on a company's quarterly financial report. Wall Street clearly dives into all of the other metrics and management's input, but the EPS figure

Buy 2 AI-Led Engineering R&D Services Stocks to Tap Solid Price Upside: https://staticx-tuner.zacks.com/images/articles/main/25/169734.webp
Buy 2 AI-Led Engineering R&D Services Stocks to Tap Solid Price Upside

Engineering – R&D (research and development) Services industry is poised to benefit from the rapid usage of artificial intelligence (AI) technologies to deliver smart buildings and mega projects

BMRN vs. ILMN: Which Stock Is the Better Value Option?Photo, wide shot, wide-angle lens,  Clinical research organization, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/02f7778c-d723-4fb3-bdef-fabb7e5fc9c8.png
BMRN vs. ILMN: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either BioMarin Pharmaceutical (BMRN) or Illumina (ILMN). But which of these two companies is the

JPMorgan Sees S&P 500 at 8,000: ETFs That Are Worth BuyingPhoto, wide shot, wide-angle lens,  Computer hardware manufacturer, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/8b396c5d-cf01-4937-89c4-91ad2f28f1ee.png
JPMorgan Sees S&P 500 at 8,000: ETFs That Are Worth Buying

A stronger earnings outlook and the potential for AI spending by major hyperscalers to accelerate revenue growth have led J.P. Morgan JPM to raise its year-end S&P 500 target to 8,000 from 7,800

Broadcom is Overvalued at 23.8X P/E: Should You Still Buy the Stock?
Broadcom is Overvalued at 23.8X P/E: Should You Still Buy the Stock?

Broadcom AVGO shares are overvalued, as suggested by a Value Score of D. In terms of the forward 12-month price/earnings (P/E), AVGO is trading at 23.8X, higher than the broader Zacks Computer and

Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now
Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now

Wall Street watches a company's quarterly report closely to understand as much as possible about its recent performance and what to expect going forward. Of course, one figure often stands out among

FJTSY or NOW: Which Is the Better Value Stock Right Now?
FJTSY or NOW: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Computers - IT Services sector might want to consider either Fujitsu Ltd. (FJTSY) or ServiceNow (NOW). But which of these two stocks presents investors with the

Why Is Wells Fargo (WFC) Up 1.6% Since Last Earnings Report?
Why Is Wells Fargo (WFC) Up 1.6% Since Last Earnings Report?

It has been about a month since the last earnings report for Wells Fargo (WFC). Shares have added about 1.6% in that time frame, underperforming the S&P 500.

Will the recent positive trend continue

AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?
AngioDynamics (ANGO) Up 8.9% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for AngioDynamics (ANGO). Shares have added about 8.9% in that time frame, outperforming the S&P 500.

But investors have to be wondering, will the